stage 2 diabetes
Showing 1 - 25 of >10,000
Type 1 Diabetes Trial (teplizumab)
Not yet recruiting
- Type 1 Diabetes
- teplizumab
- (no location specified)
Mar 6, 2023
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes
Active, not recruiting
- Type 2 Diabetes Mellitus
-
Tokyo, JapanTakeda Selected Site
Oct 28, 2022
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Charlottesville (Continuous Glucose Monitor)
Completed
- Diabetes
- +2 more
- Continuous Glucose Monitor
-
Charlottesville, VirginiaMeaghan Stumpf, MD
Nov 29, 2022
Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4, Diabetes, Type 2 Trial in Sweden (Sulforaphane, administered as
Completed
- Chronic Kidney Disease Stage 3B
- +2 more
- Sulforaphane, administered as Broccoli sprout extract
-
Göteborg, Sweden
- +7 more
Jan 16, 2023
Type 1 Diabetes, Prediabetic State, Dysglycemia Trial in Aurora (Early CGM-guided education and initiation of insulin therapy.,
Enrolling by invitation
- Type 1 Diabetes
- +3 more
- Early CGM-guided education and initiation of insulin therapy.
- Usual care: glucometer surveillance and basic education.
-
Aurora, ColoradoBarbara Davis Center
May 6, 2022
Type 2 Diabetes, End Stage Renal Disease on Dialysis Trial in Chapel Hill (Semaglutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- End Stage Renal Disease on Dialysis
- Semaglutide
- Placebo
-
Chapel Hill, North CarolinaUniversity of North Carolina
Sep 11, 2023
Type 2 Diabetes, Diabetes, Type 2, Renal Transplant Trial in London (AZD1656, Placebo)
Recruiting
- Type 2 Diabetes
- +4 more
- AZD1656
- Placebo
-
London, United KingdomRoyal London Hospital Barts Health NHS Trust
Feb 4, 2022
Loss-of-Control Eating, Obesity/Overweight Trial in New Haven (Naltrexone and Bupropion (NB) medication, Placebo)
Enrolling by invitation
- Loss-of-Control Eating
- Obesity/Overweight
- Naltrexone and Bupropion (NB) medication
- Placebo
-
New Haven, ConnecticutYale School of Medicine
Oct 4, 2022
Loss-of-control Eating, Obesity/Overweight Trial in New Haven (Lisdexamfetamine Dimesylate (Medication), Placebo)
Enrolling by invitation
- Loss-of-control Eating
- Obesity/Overweight
- Lisdexamfetamine Dimesylate (Medication)
- Placebo
-
New Haven, ConnecticutYale School of Medicine
Oct 4, 2022
Type 2 Diabetes, End Stage Renal Disease Trial in Bern, Cambridge (CamAPS HX Closed-loop, Multiple Daily Insulin Injections
Completed
- Type 2 Diabetes
- End Stage Renal Disease
- CamAPS HX Closed-loop
- Multiple Daily Insulin Injections (Control)
-
Bern, Switzerland
- +1 more
May 16, 2022
Trial of KidneyIntelX
Recruiting
- Diabetic Kidney Disease
- +4 more
- KidneyIntelX
-
New York, New YorkMount Sinai Health System
Jan 5, 2022
End-Stage Renal Disease, Type 2 Diabetes Trial in Atlanta (Dexcom real-time G6 Continuous Glucose Monitoring System (CGM), POC
Recruiting
- End-Stage Renal Disease
- Type 2 Diabetes
- Dexcom real-time G6 Continuous Glucose Monitoring System (CGM)
- POC BG
-
Atlanta, Georgia
- +1 more
Feb 18, 2022
CKD, Diabetic Kidney Disease, Type 2 Diabetes in Obese Trial in Danville, Wilkes-Barre (Semaglutide 2 mg/1.5 ml (1.34 mg/ml),
Recruiting
- CKD
- +4 more
- Semaglutide 2 mg/1.5 ml (1.34 mg/ml), prefilled pen-injector for subcutaneous injection solution
- Placebo 1.5 ml, prefilled pen-injector for subcutaneous injection solution
-
Danville, Pennsylvania
- +1 more
Feb 3, 2022
Prospective Decision Impact Trial of KidneyIntelX
Recruiting
- Diabetic Kidney Disease
- +3 more
- KidneyIntelX
-
Winston-Salem, North CarolinaAtrium Health Wake Forest Baptist - Family Medicine - Piedmont P
Nov 22, 2021
Type 1 Diabetes, Insulin-requiring Type 2 Diabetes, End Stage Renal Disease (ESRD) Trial (Artificial Pancreas, Multiple Daily
Withdrawn
- Type 1 Diabetes
- +2 more
- Artificial Pancreas
- Multiple Daily Injections
- (no location specified)
Nov 2, 2021
End Stage Renal Disease, Hypertension, Diabete Type 2 Trial in Montreal (Medication reconciliation supplemented with MedSafer
Enrolling by invitation
- End Stage Renal Disease
- +5 more
- Medication reconciliation supplemented with MedSafer and deprescribing brochures
-
Montreal, Quebec, CanadaMcGill University Health Centre
Oct 15, 2022
Type 2 Diabetes Trial in Uppsala (Metformin, Dapagliflozin 10 MG)
Recruiting
- Type 2 Diabetes
- Metformin
- Dapagliflozin 10 MG
-
Uppsala, SwedenUppsala University Hospital
Apr 27, 2021
Newly Diagnosed Type 2 Diabetes Trial in Parma (Metformin-Sitagliptin-Empaglifozin-Pioglitazone, Standard of care)
Recruiting
- Newly Diagnosed Type 2 Diabetes
- Metformin-Sitagliptin-Empaglifozin-Pioglitazone
- Standard of care
-
Parma, ItalyAzienda Ospedaliero Universitaria di Parma
Aug 10, 2021
Neuregulin-4 and Its Receptor ErbB4 in Periodontitis and Without
Recruiting
- Periodontitis
- Diabetes Mellitus
-
Cairo, EgyptCairo university Faculty of dentistry
Jun 17, 2021
Diabetes, Kidney Diseases Trial in Great Neck (Continuous Glucose Monitoring)
Completed
- Diabetes
- Kidney Diseases
- Continuous Glucose Monitoring
-
Great Neck, New YorkNorthwell Health (Division Endocrinology and Nephrology)
Mar 10, 2021
Heart Failure, Copd, Liver Failure Trial in Denver, Lafayette (Medically Tailored Meals)
Completed
- Heart Failure
- +5 more
- Medically Tailored Meals
-
Denver, Colorado
- +1 more
Feb 16, 2022
Type 2 Diabetes, Prediabetic State, Chronic Periodontitis Trial in Riyadh (Indocyanine green)
Completed
- Type 2 Diabetes Mellitus
- +2 more
- Indocyanine green
-
Riyadh, Saudi ArabiaCollege of Applied Medical Sciences, King Saud University
Apr 21, 2021
Palliative Care, Diabetes, Type 2, Diabetes, Type 1 Trial in Israel, Italy, Switzerland (Continuous Glucose Monitoring, Standard
Active, not recruiting
- Palliative Care
- +8 more
- Continuous Glucose Monitoring
- Standard Care
-
Ramat Gan, Israel
- +5 more
Jul 20, 2021
Diabetes 1 or 2, Midfoot Charcot Neuroarthropathy Trial in Rostock (Surgery with Midfoot Fusion Bolt, Cast treatment)
Terminated
- Diabetes Mellitus 1 or 2
- Midfoot Charcot Neuroarthropathy
- Surgery with Midfoot Fusion Bolt
- Cast treatment
-
Rostock, GermanyDept. of Trauma and Reconstructive Surgery, University of Rostoc
Jul 21, 2021